Results 231 to 240 of about 55,987 (284)

Antidiabetic Agents and Bone Quality: A Focus on Glycation End Products and Incretin Pathway Modulations

Journal of Bone Metabolism
Diabetes mellitus is associated with inadequate bone health and quality and heightened susceptibility to fractures, even in patients with normal or elevated bone mineral density.
Muthanna K. Zaki, M. Abed, F. Alassaf
semanticscholar   +1 more source

Verifying the effectiveness of romosozumab re-administration on bone mineral density.

Journal of Bone and Mineral Research
Upon completing romosozumab therapy for osteoporosis, sequential treatment with other agents is required. However, for patients at high fracture risk despite such therapy, re-administration of romosozumab might be a potent option for subsequent ...
T. Kobayakawa, Yukio Nakamura
semanticscholar   +1 more source

Characterization of bone lesions and bone mineral density of roadkilled wild animals in the Brazilian semi-arid

Neotropical Biology and Conservation
Highways are one of the anthropogenic factors that have the greatest impact on terrestrial biodiversity. Barriers, depletion effects, and roads are the most common locations of wild animal roadkill, leading to biodiversity loss in wild vertebrates ...
Itainara Taili, Fabiano Séllos Costa, João Marcelo Azevedo de Paula Antunes, A. Shimabukuro, Raul dos Santos, Sofia de Oliveira Cabral, C. Calabuig   +6 more
semanticscholar   +1 more source

Effects of Abaloparatide on Bone Mineral Density in Proximal Femoral Regions Corresponding to Arthroplasty Gruen Zones

Journal of Bone and Joint Surgery. American volume
Background: Low hip bone mineral density (BMD) in patients who undergo total hip arthroplasty (THA) increases the risk of periprosthetic fractures, implant instability, and other complications.
Neil P. Sheth, James Russell Smith, R. Winzenrieth, Ludovic Humbert, Yamei Wang, John I. Boxberger, Mathias P. Bostrom   +6 more
semanticscholar   +1 more source

Bone-modifying therapy in arthroplasty

Bone and soft tissue sarcomas, tumors of the skin
The use of bisphosphonates in medicine began in the 60s of the XX century due to their ability to prevent the dissolution of hydroxyapatite and thereby to reduce bone loss.
A. V. Bukharov, D. A. Erin, V. Derzhavin, A. V. Yadrina, D. O. Elkhov, M. D. Aliev, Z. K. Khuseynzoda   +6 more
semanticscholar   +1 more source

Role of bone-forming agents in the management of osteoporosis

Aging Clinical and Experimental Research, 2021
M. McClung
semanticscholar   +1 more source

Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis.

Current Drug Targets, 2017
Taoxue Wang, Qian Liu, William Tjhioe, Jinmin Zhao, Aiping Lu, Ge Zhang, R. Tan, Mengyu Zhou, Jiake Xu, H. Feng   +9 more
semanticscholar   +1 more source

Risk of Fracture and the Concomitant Use of Bisphosphonates With Osteoporosis-Inducing Medications

The Annals of Pharmacotherapy, 2015
A. Nyandege, P. Slattum, Spencer E. Harpe   +2 more
semanticscholar   +1 more source

Research Hotspots Analysis of Osteoporosis by PubMed

International Conference on Information Technology in Medicine and Education, 2015
Hou Jinjie, Wang Zhenmin, Bai Zhifeng, Guo Yicheng, Gu Guoxiao, Yuan Lijing, Li Weiming, Lin Huilong, Li Ruiyu, Liu Yang, Li Jungai   +10 more
semanticscholar   +1 more source

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women

Annals of Internal Medicine, 2017
M. Forciea, R. McLean, A. Qaseem
semanticscholar   +2 more sources